Considering that both JAK inhibitors and IL-6 blockade are effective in RA, it is plausible that JAK inhibitors mainly target IL-6 signaling and the inhibitory effect of JAK inhibitor can be explained by the inhibition of the IL-6 signaling. The gene discussed is IL6; the disease is rheumatoid arthritis.